Cargando…
Efficacy and safety of once‐daily insulin degludec dosed flexibly at convenient times vs fixed dosing at the same time each day in a Japanese cohort with type 2 diabetes: A randomized, 26‐week, treat‐to‐target trial
AIMS/INTRODUCTION: This trial assessed the efficacy and safety of the possibility of varying the daily injection time of once‐daily, long‐acting basal insulin degludec (IDeg) in Japanese patients with type 2 diabetes inadequately controlled with insulin glargine. MATERIALS AND METHODS: This was a 26...
Autores principales: | Kadowaki, Takashi, Jinnouchi, Hideaki, Kaku, Kohei, Hersløv, Malene L, Hyllested‐Winge, Jacob, Nakamura, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009133/ https://www.ncbi.nlm.nih.gov/pubmed/27182031 http://dx.doi.org/10.1111/jdi.12502 |
Ejemplares similares
-
Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data
por: Kaku, Kohei, et al.
Publicado: (2017) -
The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
por: Meneghini, Luigi, et al.
Publicado: (2013) -
Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms (BOOST
(®): SIMPLE USE)
por: Park, S. W., et al.
Publicado: (2016) -
Glargine and degludec: Solution behaviour of higher dose synthetic insulins
por: Adams, Gary G., et al.
Publicado: (2017) -
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro, Jordi, et al.
Publicado: (2016)